Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S7W-04067 · Session 7

How many applications for access to Skyclarys (omaveloxolone) have been made through the Patient Access to Care Services (PACS) Tier 2 proc…

Answered Asked by Adam Harley LD Lodged 6 Oct 2026

The question

To ask the Scottish Government how many applications for access to Skyclarys (omaveloxolone) have been made through the Patient Access to Care Services (PACS) Tier 2 process in each NHS board area since the medicine became available in the UK and, for each NHS board area, how many applications have been approved.

The answer

Answered by Angela Constance on 19 Oct 2026 · 13 days after it was lodged, on time

There is a requirement for Health Boards to maintain accurate and up to date information on Peer Approved Clinical System (PACS) Tier Two requests. The Scottish Government does not hold official validated statistical data on the number of PACS applications that Health Boards have received from clinicians for individual medicines. This information would need to be requested from Health Boards directly.

In the Official Report

No contribution in the Official Report cites S7W-04067 by reference.